BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 10089900)

  • 1. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.
    Hofmann WK; Kalina U; Wagner S; Seipelt G; Ries C; Hoelzer D; Ottmann OG
    Exp Hematol; 1999 Mar; 27(3):395-400. PubMed ID: 10089900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
    Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia.
    Adams JA; Liu Yin JA; Brereton ML; Briggs M; Burgess R; Hyde K
    Br J Haematol; 1997 Oct; 99(1):139-46. PubMed ID: 9359514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
    Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
    Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.
    Letestu R; Vitrat N; Massé A; Le Couedic JP; Lazar V; Rameau P; Wendling F; Vuillier J; Boutard P; Plouvier E; Plasse M; Favier R; Vainchenker W; Debili N
    Blood; 2000 Mar; 95(5):1633-41. PubMed ID: 10688818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
    Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N
    Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
    Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
    Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors.
    Liu Yin JA; Adams JA; Brereton ML; Hann A; Harrison BD; Briggs M
    Br J Haematol; 2000 Mar; 108(4):743-6. PubMed ID: 10792278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memorial lecture. Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
    Hofmann WK; Ottmann OG; Hoelzer D
    Leukemia; 1999 Apr; 13 Suppl 1():S14-8. PubMed ID: 10232362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets.
    Debili N; Wendling F; Cosman D; Titeux M; Florindo C; Dusanter-Fourt I; Schooley K; Methia N; Charon M; Nador R
    Blood; 1995 Jan; 85(2):391-401. PubMed ID: 7529061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective megakaryocytic development in myelodysplastic syndromes.
    Hofmann WK; Kalina U; Koschmieder S; Seipelt G; Hoelzer D; Ottmann OG
    Leuk Lymphoma; 2000 Jun; 38(1-2):13-9. PubMed ID: 10811444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia.
    Fontenay-Roupie M; Dupont JM; Picard F; Fichelson S; Botella A; Melle J; Guesnu M; Casadevall N; Dreyfus F; Bouscary D
    Leuk Res; 1998 Jun; 22(6):527-35. PubMed ID: 9678719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
    Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
    Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromes.
    Luo SS; Ogata K; Yokose N; Kato T; Dan K
    Stem Cells; 2000; 18(2):112-9. PubMed ID: 10742383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of c-mpl expression in myelodysplastic syndromes.
    Bouscary D; Preudhomme C; Ribrag V; Melle J; Viguié F; Picard F; Guesnu M; Fenaux P; Gisselbrecht S; Dreyfus F
    Leukemia; 1995 May; 9(5):783-8. PubMed ID: 7539513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture.
    Guerriero R; Testa U; Gabbianelli M; Mattia G; Montesoro E; Macioce G; Pace A; Ziegler B; Hassan HJ; Peschle C
    Blood; 1995 Nov; 86(10):3725-36. PubMed ID: 7579339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
    Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
    Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic stem cell differentiation to hematopoietic cells: A model to study the function of various regions of the intracytoplasmic domain of cytokine receptors in vitro.
    Filippi MD; Porteu F; Le Pesteur F; Rameau P; Nogueira MM; Debili N; Vainchenker W; de Sauvage FJ; Kupperschmitt AD; Sainteny F
    Exp Hematol; 2000 Dec; 28(12):1363-72. PubMed ID: 11146158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
    Alexander WS; Roberts AW; Nicola NA; Li R; Metcalf D
    Blood; 1996 Mar; 87(6):2162-70. PubMed ID: 8630375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.